FENCFennec Pharmaceuticals Inc.
What is the market doing?
No clear lean: rangebound and lightly shorted.
Choppy, but holding above its 200-day average. Price is +10% vs its 200-day average.
Lightly shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How FENC is trading
Fennec Pharmaceuticals Inc. is +15% over the past year while the S&P 500 is +16%: 0.53 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +10%
vs 200-day average · a clear uptrend
- RSI (14)
- 41
RSI (14) · neutral
- Below its 52-week high
- 21%
Below its 52-week high
Details›
- Last close2026-10-23
- $10.07
- 1 monthS&P 500 −0.94%
- −4.9%
- 1 yearS&P 500 +16%
- +15%
- 5 yearsS&P 500 +86%
- +9.6%
- vs 50-day average$11.05
- −8.8%
- 52-week high
- $12.78
- 52-week low
- $5.77
- Annualised volatility
- 62%
| Year | Return |
|---|---|
| 2026 (year to date) | +31% |
| 2025 | +22% |
| 2024 | −44% |
| 2023 | +17% |
| 2022 | +118% |
| 2021 | −41% |
| 2020 | +15% |
| 2019 | +1.7% |
| 2018 | −36% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 5 of 9 | −0.79% |
| Feb | 9 | 6 of 9 | +3.7% |
| Mar | 9 | 3 of 9 | −6.1% |
| Apr | 9 | 5 of 9 | −1.1% |
| May | 9 | 4 of 9 | +7.3% |
| Jun | 9 | 5 of 9 | +2.6% |
| Jul | 9 | 5 of 9 | +1.1% |
| Aug | 9 | 5 of 9 | +0.24% |
| Sep | 9 | 5 of 9 | +1.9% |
| Oct | 10 | 3 of 10 | −2.2% |
| Nov | 9 | 6 of 9 | +4.1% |
| Dec | 9 | 5 of 9 | +2.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.